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A case of a canine oral eosinophilic granuloma in a 14-year-old female crossbred is described.The dog was presented with a history
of ptyalism, halitosis, local pain, decreased appetite, and blood staining noted on food and water bowls. Clinical, hematologic,
and biochemical examinations, abdominal ultrasonography, and 3-view chest radiographs were performed, and no metastases
were found. Histopathologic examination of two 6mm punch biopsies from the oral lesion revealed the presence of eosinophilic
granulomatous lesions in the submucosa. After treatment with corticosteroids andwide spectrum antibiotics no significant changes
in clinical signs and lesion size were observed. Electrochemotherapy (ECT), a novel tumor treatment routinely used for cutaneous
and subcutaneous tumors in human patients in the European Union since 2006, was used to treat the eosinophilic granuloma.The
procedure was performed under general anesthesia, followed by intravenous administration of bleomycin. Six weeks after treatment
a complete response with disappearance of the mass and improvement of clinical signs were observed.
1. Introduction
Canine eosinophilic granuloma is an eosinophilic disease
reported as a rare lesion characterized by nodules and plaques
in themouth, tonsils, or skin.The exact cause is unknown, but
infectious agents as bacteria, parasites, or fungal organisms
have been implicated in the pathogenesis. Siberian Huskies
andCavalier KingCharles Spaniels aremost commonly affec-
ted [1, 2]. Few studies have documented the disease in older
crossbred dogs. Oral lesions are characterized by plaques or
proliferative masses. These are most commonly found on the
palate and the lateral or ventral side of the tongue. Oral
lesions may be painful and halitosis is usually the presenting
complaint.
The etiology of these lesions remains unknown, although
an underlying allergic condition is likely. This disease occurs
in dogs as a collagen tissue degeneration [1, 3–5]. In humans,
some reports have proposed several mechanisms of patho-
genesis as vasculitis, microangiopathies, fibromatosis, phago-
cytic dysfunction, and cell mediated immune-response dys-
function [6].
Standard treatments are made with the aim of reducing
the size of the granuloma and to improve the general condi-
tion of the patient. A treatment with antibiotic and corti-
costeroid therapy has been reported with a partial response
and occurrence of side effects such as gastritis, enteritis, and
chronic renal failure due to prolonged use of high doses of
corticosteroids in older patients [3].The surgical excision fol-
lowed by immunosuppressive therapy with corticosteroids or
azathioprine might achieve best local results, but in patients
with large masses aggressive procedure is necessary. Also, a
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high rate of recurrence was observed after a short treatment
period [2, 3, 7].
ECT is a novel treatment modality consisting in the use
of an electric field to increase tissue permeability to certain
drugs [8, 9]. Bleomycin is usually the drug of choice, which
works as an endonuclease, cutting the DNA strands and thus
interferingwith cell division.This provides a sort of selectivity
towards dividing cells, sparing the quiescent ones and thus
allowing the tissue to heal withminimum scaring. It has been
used in the European Union since 2006, for the treatment
of cutaneous and subcutaneous tumors [10, 11], particularly
for the treatment of melanoma nodules. Cemazar et al.
reviewed the use of electrochemotherapy for treating tumors
in veterinary oncology [12].
In this case report we show for the first time the use
of electrochemotherapy for the treatment of a canine eosino-
philic granuloma, a nononcological disease.
2. Case Presentation
A case of a 14-year-old canine female crossbred is described.
The dog was presented with a history of ptyalism, halitosis,
mild weight loss, local pain, decreased appetite, and blood
staining noted on food and water bowls.
2.1. Clinical Examination. The patient’s general condition
was good on the physical exam; hypersalivation, halitosis,
and uncomfortable chewing were the main clinical signs. A
3.8 × 2.2 × 1.2 cm bloody mass was found on the lower right
side of the mouth (Figure 1). We also detected a right sub-
mandibular lymph node enlargement; thus a fine needle aspi-
ration was performed. Complete laboratory analysis, abdo-
minal ultrasound, and 3-view thoracic radiographs were
performed as a first clinical staging.The blood count revealed
mild anemia (29% hematocrit, reference range 35–55%),
mild leukocytosis (36 × 103 leukocytes/𝜇L, reference range
6.0–12.0 × 103 leukocytes/𝜇L), an increased percentage of
segmented neutrophilic granulocytes (83%, reference range
60–75%), 13% lymphocytes (reference range 15–30%), 4%
eosinophils (reference range 0–6%), and slight thrombocy-
topenia (250 × 103 platelets/𝜇L, reference range 300–500 ×
10
3 platelets/𝜇L). The routine biochemical parameters were
within the normal range. The cytology from the fine needle
aspiration showed a reactive lymph node, likely due to the
oral inflammation and infection. No metastatic signs were
observed on the imaging studies; therefore two samples of
6mm punch biopsy were taken from the mass to be referred
to the pathologist.
Two formalin fixed samples were embedded in paraffin
wax and then stained with hematoxylin and eosin (HE).
The histopathology samples revealed a chronic eosinophilic
granuloma consisting of densely eosinophilic material rep-
resenting remnants of fragmented collagen bundles and
degenerate eosinophils which have released their granules to
the interstitium. At the periphery of the granuloma, mainly
differentiated fibrovascular tissue can be seen with some
eosinophilic granulocytes intermingled with small numbers
Figure 1: Picture taken on day 1, before the ECT treatment. On the
right side of the mouth a 3.8 × 2.2 × 1.2 cm bloody mass can be seen
corresponding to an eosinophilic granuloma.
of lymphocytes, macrophages, plasma cells, and neutrophils
(Figure 2).
2.2. Treatment. After a treatment with prednisolone
2mg/kg/sid and amoxicillin/clavulanic acid 62.5mg/kg/bid,
no significant changes in clinical signs and lesion size were
observed.
A wide-margin surgical excision was indicated to ensure
that all eosinophilic granuloma is removed, but this indica-
tionwas not accepted by pet owners. For this reason, ECTwas
the therapeutic modality chosen and an informed consent
was signed. Local regulations were followed (Argentina, law
N∘ 14,072) [13].
The treatment was performed under general anesthesia.
The patient was induced with intravenous bolus of propofol
(3mg/kg) and diazepam (0.5mg/kg) and maintained after
tracheal intubation with isoflurane and intravenous fentanyl
(2 𝜇g/kg). This scheme of anesthesia guarantees an adequate
comfort of the patient during the treatment. Prophylactic
antibiotics were administered.
A single dose of bleomycin (15,000 IU/m2) was admin-
istered in bolus, and the electric pulses were delivered 8
minutes later, applying 8 pulses of 800V/cm and 100 𝜇sec
long at a repetition frequency of 10Hz, covering the whole
lesion surface, using a pulse generator BTX ECM 830, Har-
vard Apparatus, Boston, USA. We used a 6-needle electrode
(Figure 3), as the area covered with the electrode is 0.8 ×
0.8 cm; 15 applications were needed to cover the lesion
and superposition was avoided. After the procedure, oral
meloxicam (0.1mg/kg/sid) was administered for pain and
local swelling control.
To determine the dose of bleomycin the body surface of
the dog was estimated using the following formula [14]:
body surface in m2 =
10.1 × (weight in grams)2/3
10 000
. (1)
The weight was 8.9 kg; thus the calculated body surface was
0.434m2.
2.3. Followup. Four days after ECT, the patient showed mild
inflammation of the gingiva, but no significant changes in
food and water intake were observed by the pet owner.
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Figure 2: Histopathology samples stained with hematoxylin and eosin revealed a chronic eosinophilic granuloma consisting of densely
eosinophilicmaterial representing remnants of fragmented collagen bundles and degenerate eosinophils which have released their granules to
the interstitium.At the periphery of the granuloma,mainly differentiated fibrovascular tissue can be seenwith some eosinophilic granulocytes
intermingled with small numbers of lymphocytes, macrophages, plasma cells, and neutrophils (scale bars = 100 𝜇m).
Figure 3: Six-needle electrode used to treat the patient. It consists
of two rows of 3 needles. The separation of the rows is 0.8 cm; the
separation between the needles in the same row is 0.4 cm. Each
needle is 2 cm long and 1.2mm in diameter.
14 days after ECT, no signs of inflammation or a clear
improvement in general condition due to the partial reduc-
tion of the mass were observed. Meloxicam was discontinued
due to lack of inflammation.
45 days after treatment (Figure 4) improvement of life
quality was observed to be likely related to absence of pain;
also decreased sialorrhea and halitosis were obvious. In
accordance with the World Health Organization response
criteria [15], a complete remission with a 100% reduction of
the lesion size was observed.
After day 45, one month of corticosteroid therapy with
prednisolone 1.5mg/kg/sid and omeprazole 1mg/kg/sid was
indicated to prevent local recurrence.
3. Conclusions and Discussion
The standard treatment for the eosinophilic granuloma has
a very low efficacy and most of its side effects may seriously
affect the quality of life of the patient. We conclude that, in
this case of canine oral eosinophilic granuloma, ECT was a
very good treatment option with excellent results. This result
confirms that one of themost remarkable aspects of ECT is its
effectiveness against any histological type of tumor [12, 16, 17].
As ECT kills proliferating cellsmainly by apoptosis, quiescent
Figure 4: Picture taken 45 days after the ECT treatment. A complete
response was achieved.
cells are preserved. In this case, ECT was a logical treatment
option since it will affect the replicating cells in the lesion
without affecting the others, even though they were not
oncological cells.
Although intratumoral administration of bleomycin is
usually recommended in human treatments [17], we decided
to use a systemic administration whereas this disease consists
of an heterogeneous tissue; thus, the local injection of bleo-
mycin would probably not provide a uniform distribution
inside the granuloma in our case.
Our data also confirm that ECT is very useful when
the patient’s clinical condition impedes a more aggressive
treatment. ECT is a cancer treatment modality that has not
been used routinely in nononcological diseases [18]. In this
case, this modality of treatment achieved excellent results
treating eosinophilic granuloma.Thepatient regained its gen-
eral condition after a few days, with a rapid overall improve-
ment. The low doses of bleomycin (11 to 30 times lower
dose than the one reported as toxic [19]) had no undesired
effects. However, the treatment provoked a mild swelling of
the gingiva and oral discomfort after the ECT. The situation
ceased in less than seven days, controlled with nonsteroidal
anti-inflammatory drugs (NSAIDs). It must be noticed that,
prior to the ECT treatment, the lesion itself made the food
and water intake very difficult. Thus, this side effect was
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quite limited in time and it was actually compensated by the
efficacy of the ECT.
The ECT proves to be very useful in cases of a large size
granuloma that cannot be reduced considerably by standard
treatments based on immunosuppression. The major advan-
tage of ECT could be for treating cases where the owner
rejects the radical surgical excision or in those cases where
high dose corticosteroids therapy is not a viable option.
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